StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.83−0.31 (-4.34%)

Close on Nov 17, 2026Market cap $133.03MP/E –Yield –

Moleculin Biotech price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Moleculin Biotech's price to book ratio was 5.0× on Nov 11, 2026, against 17.8× a year earlier. Over the last 5 years it ranged from 2.8× to 23.6×, with a median of 9.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.0×−7.9
2025Jul 31, 202512.9×+7.0
2024Dec 31, 20245.9×−8.7
2023Dec 29, 202314.6×+4.2
2022Dec 30, 202210.4×−2.7
2021Dec 31, 202113.1×−55.0
2020Dec 31, 202068.1×+24.0
2019Dec 31, 201944.1×+6.8
2018Dec 31, 201837.3×−4.2
2017Dec 29, 201741.5×+7.7
2016Dec 30, 201633.8×–

More Moleculin Biotech figures

See a number that looks wrong?